Bicarbonate

OTHER5 trials

Sponsors

Wake Forest University Health Sciences, Azienda Sanitaria ASL Avellino 2, Insel Gruppe AG, University Hospital Bern, Uludag University, McMaster University

Conditions

Chemotherapy EffectColon CancerEnd Stage Renal Failure on DialysisHemodialysisKidney Failure, AcuteMetabolic AcidosisNurse's RoleOral Mucositis

Phase 2

Use of Bicarbonate to Reduce the Incidence of Acute Renal Failure After Cardiac Surgery

CompletedNCT00484354

Wake Forest University Health SciencesKidney Failure, Acute, Renal Replacement Therapy

Start: 2006-05-31End: 2013-12-31Updated: 2018-10-16

Phase 3

Correction of Metabolic Acidosis in End Stage Renal Disease (ESRD)

Azienda Sanitaria ASL Avellino 2Metabolic Acidosis

Start: 2014-07-31End: 2017-12-31Target: 728Updated: 2014-09-19

Unknown Phase

Pilot Study to Investigate the Effects of Increased Dialysate Magnesium and Dialysate Bicarbonate on the Calcification Propensity of Serum

CompletedNCT02621762

Insel Gruppe AG, University Hospital BernEnd Stage Renal Failure on Dialysis, Vascular Calcification

Start: 2015-12-31End: 2016-05-31Updated: 2017-09-26

The Effects of Ankaferd Blood Stopper

Uludag UniversityChemotherapy Effect, Colon Cancer, Nurse's Role +1

Start: 2021-06-01End: 2023-06-02Target: 66Updated: 2023-06-01

Dial-Bicarb Trial: Effects of a Lower vs. Higher Concentration of Dialysate Bicarbonate

Not yet recruitingNCT06270134

McMaster UniversityHemodialysis, Renal Failure

Start: 2025-04-30End: 2029-04-30Target: 14000Updated: 2025-03-20

Related Papers

The effects of Ankaferd hemostat on preventing oral mucositis in colorectal cancer patients receiving chemotherapy.

2023-06-08

Treatment of metabolic acidosis with sodium bicarbonate delays progression of chronic kidney disease: the UBI Study

Journal of Nephrology2019-10-09162 citations

Correction of metabolic acidosis improves insulin resistance in chronic kidney disease.

2016-10-2265 citations